Device / Technology News

RSS

FDA clears Burton Medical's AIM-200 O.R. for surgical lighting applications

Burton Medical, Inc., the leader in examination and minor surgery lighting equipment, has received FDA clearance for its AIM-200® O.R. light for surgical lighting applications in operating rooms for ambulatory surgical centers as well as acute care facilities.

21 Oct 2010

Nexcore announces acquisition of Meditron product line from CooperSurgical

Nexcore Technologies, Inc. of Waldwick, an original equipment manufacturer of medical devices, today announced it has acquired the Meditron line of gastroenterology endoscopy products from CooperSurgical, Inc. of Trumbull, CT.

21 Oct 2010

Thomson Reuters introduces new version of Clinical Xpert Navigator

Thomson Reuters, a global provider of information for healthcare professionals, has released the newest version of its award-winning Clinical Xpert Navigator mobile clinical data application.

21 Oct 2010

Z-Medica enters agreement with two Swedish medical device distributors for QuikClot products

Z-Medica Corporation, a medical device company developing innovative hemostatic agents, today announced that it has signed exclusive distribution agreements with Vingmed AB and Mediplast AB, two leading Swedish medical device distributors, for distribution of its QuikClot line of hemostatic agents in Sweden, Denmark and Norway for the first time.

From Medica Corporation 21 Oct 2010

Nightingale signs over 400 EMR seats in Canada during first half of fiscal 2011

Nightingale Informatix Corporation, an application service provider (ASP) of electronic medical record (EMR) software and related services today announced that during its fiscal 2011 second quarter ended September 30, it signed agreements to deploy its Nightingale On Demand EMR and practice management solution with healthcare providers across Canada, representing more than 200 seats (A "Seat" is defined as a paying healthcare provider using Nightingale's Electronic Medical Record).

20 Oct 2010

Atrius selects Sightlines, DxCG Risk solutions for healthcare processes

Verisk Health, Inc., announced today that Atrius Health has selected Sightlines Medical Intelligence and DxCG Risk Solutions to identify, manage, and predict healthcare risk across its commercial, Medicaid, and Medicare populations.

20 Oct 2010

FDA purchases AB SCIEX QTRAP 5500 Systems for analysis of the U.S. food supply

AB SCIEX, a global leader in life science analytical technologies, today announced that the U.S. Food and Drug Administration has purchased eight of the company's AB SCIEX QTRAP® 5500 Systems for analysis of the U.S. food supply. These mass spectrometry systems will be deployed at FDA headquarters and across seven field laboratories. This supports government initiatives to help ensure food safety.

20 Oct 2010

NMT releases new device for treatment of post-operative nausea

Neurowave Medical Technologies™ today announced the release of an innovative new device for the treatment of post-operative nausea, medically referred to as emesis. Reletex™ is a novel transdermal neuromodulation device that is non-invasive and drug-free, and has been demonstrated to alleviate nausea when used as an adjunct to anti-emetics.

20 Oct 2010

RWV bioreactor creates 3-D cell culture models

The cells and tissues in our bodies grow, develop and interact in a highly complex, three-dimensional world. Likewise, the various microbial pathogens that invade our bodies and cause infectious disease interact with this complex 3-D tissue milieu. In the current issue of the journal Nature Reviews Microbiology, researcher Cheryl Nickerson and her team at the Biodesign Institute at Arizona State University highlight an innovative approach for studying cells in 3-D.

20 Oct 2010

Retina Implant's first clinical trial results presented at 2010 AAO annual meeting

Retina Implant AG, a leading developer of subretinal implants for the visually impaired, is proud to announce Co-Founder and Chairman Eberhart Zrenner, M.D. was invited to present the exciting results of clinical trials he has been leading since 2005 by the American Academy of Ophthalmology at this year's annual meeting that took place October 16-19 at McCormick Place in Chicago, Ill.

20 Oct 2010

New sensor uses frog peptides to detect contamination in drugs, medical devices

Princeton engineers have developed a sensor that may revolutionize how drugs and medical devices are tested for contamination, and in the process also help ensure the survival of two species of threatened animals.

20 Oct 2010

New brush optrode improves optical scanning of brain activity

One of the main techniques for measuring and monitoring mental activity, called functional near infrared spectroscopy (fNIRS), can often be impaired because a person's hair gets in the way. But now, thanks to a team of researchers at the University of Texas at Dallas and the University of Texas at Arlington, a novel device called a "brush optrode" is providing increased sensitivity with fiber tips designed to thread through hair to enhance scalp contact.

20 Oct 2010

Minnesota health care organizations share patient EHRs through network of interoperable systems

Eight of the largest health care organizations in Minnesota have successfully launched software that enables electronic sharing of patient records across the group - and with other network members nationwide. The network of interoperable systems allows for an estimated 75 percent of Minnesotans (3.6 million patients) to show up at any one of the organizations' hospitals or clinics and have records from previous visits immediately available to doctors.

20 Oct 2010

First in vivo screening system for complete human nuclear hormone receptor family

The InDanio screening system can be used, for example, to functionally characterize 'orphan' receptors - those for which their natural ligands or specific function are unknown - and thus qualify them as potential targets for drug discovery. The system can also be used to screen compound libraries in order to identify and refine potential new drugs that target NR proteins.

20 Oct 2010

Vivakor enters global licensing agreement with MIT Holding for Vivathermic Vials

Vivakor, Inc. announces today that it has entered into an exclusive licensing agreement with MIT Holding Inc. to manage all distribution of its Vivathermic Vials worldwide. Chairman Matt Nicosia adds the following statement to the news: "This is a great step forward in the distribution of Vivakor technology.

20 Oct 2010

Pharsight launches Phoenix Pharmacometric Productivity Challenge

Pharsight, a market-leading provider of software and scientific consulting services to improve productivity and decision-making in clinical drug development, announced today that it has launched the Phoenix Pharmacometric Productivity Challenge, a competition to recognize excellence in the application of pharmacometric software to critical problems in drug development.

20 Oct 2010

Microsulis tissue ablation systems presented at London meeting

Dr Peter Clegg, from the University of Bath microwave science team, who invented and developed the Microsulis microwave tissue ablation systems for destroying tumours, presented an overview of the success of this technology at the recent 'Changing Worlds Showcase Impact of University Research' meeting held in London.

20 Oct 2010

UTHSC-Houston initiates enrollment in NanoLogix technology trial for detection of GBS in pregnant women

NanoLogix, an innovator in the accelerated detection and identification of microorganisms, announced today that the University of Texas Health Science Center in Houston is enrolling 300 patients in an ongoing clinical trial to study the speed and accuracy of NanoLogix technology. The trial is designed to compare NanoLogix technology to current methods in use for detection and identification of Group B Streptococcus (GBS) in pregnant women.

20 Oct 2010

EPO grants new patent to Silence Therapeutics’ RNAi structural modification technology

Silence Therapeutics plc announces that the European Patent Office (EPO) has granted a new patent that provides broad protection on novel aspects of the RNAi structural modification technology known as the Zamore Design Rules.

20 Oct 2010

Vitro signs contract with HemoGenix to manufacture, distribute stem cell analysis tools

Vitro Diagnostics, Inc., dba Vitro Biopharma, announced that it signed an amendment to its contract to jointly manufacture and distribute stem cell analysis tools with HemoGenix, Inc., a leading firm known for its pioneering HALO analysis platform for stem cells.

20 Oct 2010

Device / Technology News

FDA clears Burton Medical's AIM-200 O.R. for surgical lighting applications

Nexcore announces acquisition of Meditron product line from CooperSurgical

Thomson Reuters introduces new version of Clinical Xpert Navigator

Z-Medica enters agreement with two Swedish medical device distributors for QuikClot products

Nightingale signs over 400 EMR seats in Canada during first half of fiscal 2011

Atrius selects Sightlines, DxCG Risk solutions for healthcare processes

FDA purchases AB SCIEX QTRAP 5500 Systems for analysis of the U.S. food supply

NMT releases new device for treatment of post-operative nausea

RWV bioreactor creates 3-D cell culture models

Retina Implant's first clinical trial results presented at 2010 AAO annual meeting

New sensor uses frog peptides to detect contamination in drugs, medical devices

New brush optrode improves optical scanning of brain activity

Minnesota health care organizations share patient EHRs through network of interoperable systems

First in vivo screening system for complete human nuclear hormone receptor family

Vivakor enters global licensing agreement with MIT Holding for Vivathermic Vials

Pharsight launches Phoenix Pharmacometric Productivity Challenge

Microsulis tissue ablation systems presented at London meeting

UTHSC-Houston initiates enrollment in NanoLogix technology trial for detection of GBS in pregnant women

EPO grants new patent to Silence Therapeutics’ RNAi structural modification technology

Vitro signs contract with HemoGenix to manufacture, distribute stem cell analysis tools

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

Latest News